Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$41.39 - $81.0 $861,450 - $1.69 Million
-20,813 Reduced 45.3%
25,132 $1.13 Million
Q3 2022

Nov 15, 2022

BUY
$72.36 - $113.1 $19,826 - $30,989
274 Added 0.6%
45,945 $3.33 Million
Q2 2022

Aug 16, 2022

BUY
$87.2 - $114.05 $14,998 - $19,616
172 Added 0.38%
45,671 $4.9 Million
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $27,880 - $36,849
296 Added 0.65%
45,499 $5.05 Million
Q4 2021

Feb 15, 2022

SELL
$119.57 - $139.07 $18,772 - $21,833
-157 Reduced 0.35%
45,203 $5.79 Million
Q3 2021

Nov 17, 2021

SELL
$109.17 - $142.35 $370,522 - $483,135
-3,394 Reduced 6.96%
45,360 $6.04 Million
Q2 2021

Aug 18, 2021

SELL
$100.34 - $115.69 $62,411 - $71,959
-622 Reduced 1.26%
48,754 $5.27 Million
Q1 2021

May 21, 2021

SELL
$101.51 - $125.27 $1.21 Million - $1.5 Million
-11,951 Reduced 19.49%
49,376 $5.2 Million
Q4 2020

Feb 16, 2021

SELL
$85.88 - $105.36 $242,095 - $297,009
-2,819 Reduced 4.39%
61,327 $6.38 Million
Q3 2020

Nov 17, 2020

SELL
$72.74 - $92.5 $75,358 - $95,830
-1,036 Reduced 1.59%
64,146 $5.5 Million
Q2 2020

Aug 13, 2020

SELL
$48.02 - $79.04 $1.35 Million - $2.22 Million
-28,053 Reduced 30.09%
65,182 $4.78 Million
Q1 2020

May 18, 2020

SELL
$36.95 - $62.95 $161,767 - $275,595
-4,378 Reduced 4.49%
93,235 $4.84 Million
Q4 2019

Feb 18, 2020

BUY
$47.06 - $56.64 $40,706 - $48,993
865 Added 0.89%
97,613 $5.5 Million
Q3 2019

Nov 26, 2019

BUY
$47.45 - $58.05 $5,504 - $6,733
116 Added 0.12%
96,748 $4.61 Million
Q2 2019

Aug 19, 2019

SELL
$39.26 - $54.21 $232,105 - $320,489
-5,912 Reduced 5.77%
96,632 $5.24 Million
Q1 2019

May 15, 2019

BUY
$29.84 - $43.92 $1.8 Million - $2.65 Million
60,395 Added 143.29%
102,544 $4.16 Million
Q4 2018

Feb 15, 2019

SELL
$29.95 - $46.34 $1.82 Million - $2.82 Million
-60,896 Reduced 59.1%
42,149 $1.31 Million
Q3 2018

Nov 14, 2018

SELL
$40.12 - $45.55 $11,233 - $12,754
-280 Reduced 0.27%
103,045 $4.69 Million
Q2 2018

Aug 15, 2018

SELL
$38.72 - $42.52 $23,232 - $25,512
-600 Reduced 0.58%
103,325 $4.33 Million
Q1 2018

May 15, 2018

SELL
$39.4 - $47.39 $22,458 - $27,012
-570 Reduced 0.55%
103,925 $4.27 Million
Q4 2017

Feb 14, 2018

BUY
$37.27 - $43.02 $1.52 Million - $1.76 Million
40,795 Added 64.04%
104,495 $4.29 Million
Q3 2017

Nov 15, 2017

BUY
$33.75 - $41.67 $2.15 Million - $2.65 Million
63,700
63,700 $2.54 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Colony Group LLC Portfolio

Follow Colony Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.